Our collaboration with Elsevier’s The Hive program continues with a new blog post entry! In our previous blog post we detailed how Elsevier’s suite of R&D solutions have been helping us in boosting our Research (Read it here). This time we focus on our business model of partnerships and co-development to detect and develop promising technologies in the field of cancer and inflammatory diseases.
Read our latest blog post: https://pharma.elsevier.com/pharma-rd/leveraging-partnerships-rescue-develop-promising-technologies/
